USA News

Johnson & Johnson’s COVID vaccine supply to drop next week

California’s scheduled full reopening on June 15 is counting on millions of residents being vaccinated.

But recently released federal data raises new questions about whether the offer will meet expectations.

While California’s allocations for the Pfizer-BioNTech and Moderna vaccines are expected to remain relatively stable until next week, the state – as well as the rest of the country – will see a crater in availability for the Johnson & single-injection vaccine. Johnson.

This week, 574,900 doses of Johnson & Johnson were attributed to the Golden State. Next week, that number will drop to 67,600, a drop of 88%, according to CDC data.

The allowance is expected to drop further the week of April 18, to 22,400, according to the California Department of Public Health.

“To put that into perspective, the supply forecast for the next two weeks is roughly what the state received in the second half of March,” department spokesman Darrel Ng wrote on Thursday.

This dive for Johnson & Johnson will reduce the size of the state’s federal allocation from the 2.4 million doses received this week, to 2 million next week and 1.9 million the following week.

However, Ng stressed that “there are multiple vaccine supply streams coming into the state.” The direct state allocation accounts for about 70% of the total, with the remainder going directly from the federal government to pharmacies, health centers and other qualified entities.

It is not known how long it will take to reverse the drop in supply. Regardless, Ng said California will expand eligibility as planned next week.

Newsom admitted earlier this week that the Johnson & Johnson vaccine supply remained uncertain, but said he hoped for more stability.

“We have a lot of confidence in the medium and long term,” he said, “which means that the short term variability with J&J is starting to give way to more confidence in May,” with l ‘hope the vaccine’ will come in at a much higher and more predictable number. “

The availability – or lack thereof – of the Johnson & Johnson vaccine is not a problem just for California. National allocations are expected to drop from nearly 5 million this week to 700,000 next week.

The deployment of the Johnson & Johnson vaccine has been inconsistent and hampered by production issues. Last week, the company said a batch of the vaccine failed quality standards and could not be used. The drugmaker did not disclose the number of doses affected, although press reports put the number at 15 million.

To date, providers across California have distributed nearly 20.9 million doses of the COVID-19 vaccine and 35.1% of residents have received at least one vaccine, according to data from the Centers for Disease Control and Prevention.

About 18.8% of Californians are fully vaccinated, which means they have received either the Johnson & Johnson single injection vaccine or the required two doses of the Pfizer-BioNTech or Moderna vaccine.

Nationwide, 33.1% of Americans have received at least one dose and 19.4% are fully immunized, according to CDC data.

During the early phases of the vaccine’s deployment, California restricted access to vaccines to those considered most at risk of COVID-19, either because of their age, occupation, or sub-health conditions. underlying.

President Biden initially said states should make all adults eligible for COVID-19 vaccines by May 1. But he announced a more aggressive timeline – setting a deadline for April 19.





Source link

Back to top button